Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.92 USD | +1.73% | +23.72% | +59.96% |
02:52pm | Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating | MT |
02:51pm | Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating | MT |
Chart calendar RxSight, Inc.
Upcoming events on RxSight, Inc.
Past events on RxSight, Inc.
2024-05-06 04:30 pm | Q1 2024 Earnings Call |
2024-05-06 04:05 pm | Q1 2024 Earnings Release |
2024-04-10 03:45 pm | Needham Healthcare Conference |
2024-03-13 11:20 am | Oppenheimer Healthcare MedTech & Services Conference |
2024-02-28 04:30 pm | Q4 2023 Earnings Call |
2024-02-28 03:05 pm | Q4 2023 Earnings Release |
2024-01-10 06:00 pm | JPMorgan Healthcare Conference |
2023-11-09 04:30 pm | Q3 2023 Earnings Call |
2023-11-09 04:05 pm | Q3 2023 Earnings Release |
2023-11-02 | American Academy Of Ophthalmology Meeting |
2023-09-06 04:30 pm | Wells Fargo Healthcare Conference |
2023-08-07 04:30 pm | Q2 2023 Earnings Call |
2023-08-07 04:05 pm | Q2 2023 Earnings Release |
2023-05-10 06:55 pm | Bank of America Healthcare Conference |
2023-05-09 04:30 pm | Q1 2023 Earnings Call |
2023-05-09 04:05 pm | Q1 2023 Earnings Release |
2023-05-07 07:45 pm | The American Society of Cataract & Refractive Surgery Meeting |
2023-05-07 07:40 pm | American Society of Cataract and Refractive Surgery Meeting |
2023-05-07 05:29 pm | The American Society of Cataract & Refractive Surgery Meeting |
2023-05-07 04:57 pm | American Society of Cataract and Refractive Surgery Meeting |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 22,6 21,9 2.97% | 49,0 49,0 0% | 89,1 88,4 0.79% | 135 |
EBITDA Million USD | Released Forecast Spread | -48,8 -49,3 0.99% | -59,4 -64,2 7.43% | -46,0 -44,6 -3.2% | -28,0 |
EBIT Million USD | Released Forecast Spread | -52,8 -55,4 4.66% | -63,3 -68,1 7.06% | -50,1 -51,1 1.92% | -35,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,7 -49,6 1.76% | -66,7 -72,6 8.05% | -48,6 -52,2 6.89% | -31,6 |
Net income Million USD | Released Forecast Spread | -48,7 -49,4 1.45% | -66,8 -72,0 7.26% | -48,6 -52,2 6.94% | -31,4 |
EPS USD | Released Forecast Spread | -3,57 -2,66 -34.41% | -2,41 -2,61 7.52% | -1,41 -1,53 7.58% | -0,86 |
Announcement Date | 08/03/22 | 06/03/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 8,94 7,33 22.01% | 11,4 10,6 7.68% | 12,6 11,0 14.91% | 16,1 16,1 -0.08% | 17,5 16,3 7.41% | 20,8 19,2 8.23% | 22,2 20,6 8.01% | 28,6 27,9 2.6% | 29,5 27,6 7.09% | 32,2 | 33,3 | 40,1 | 38,0 | 42,2 |
EBITDA Million USD | Released Forecast Spread | -15,6 -11,0 -41.47% | -14,8 -13,6 -8.7% | -15,0 -15,6 3.92% | -14,1 -18,8 25.31% | -8,85 -13,7 35.54% | -12,6 -12,9 2.14% | -11,4 -13,0 11.89% | -9,80 -14,0 29.93% | -4,86 -9,15 46.91% | -7,34 | -7,14 | -4,93 | -5,10 | -2,60 |
EBIT Million USD | Released Forecast Spread | -16,6 -16,7 0.58% | -15,8 -18,2 13.23% | -16,0 -18,8 15.02% | -15,0 -19,8 24.32% | -13,1 -16,9 22.48% | -13,6 -15,3 10.95% | -12,5 -15,6 19.55% | -10,9 -13,8 21.62% | -10,7 -11,7 9.01% | -10,2 | -10,0 | -6,70 | -7,75 | -5,95 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,6 -16,6 -5.98% | -16,7 -19,4 13.6% | -16,8 -20,2 16.6% | -15,6 -21,7 27.92% | -13,2 -17,3 23.72% | -13,8 -15,7 12.47% | -12,4 -15,5 20.19% | -9,19 -12,5 26.21% | -9,09 -11,0 17.23% | -9,16 | -9,28 | -5,32 | -6,95 | -5,15 |
Net income Million USD | Released Forecast Spread | -17,6 -17,2 -2.58% | -16,7 -19,4 13.75% | -16,8 -19,8 15.27% | -15,6 -21,5 27.31% | -13,2 -17,4 23.9% | -13,8 -15,8 12.74% | -12,4 -15,4 19.57% | -9,18 -12,8 28.09% | -9,10 -10,7 15.21% | -9,24 | -9,24 | -6,01 | -6,95 | -5,15 |
EPS USD | Released Forecast Spread | -0,64 -0,64 -0.22% | -0,61 -0,70 12.35% | -0,61 -0,71 14.48% | -0,56 -0,75 24.99% | -0,42 -0,53 20.65% | -0,40 -0,47 14.9% | -0,35 -0,43 19.21% | -0,26 -0,38 31.8% | -0,25 -0,29 15.05% | -0,25 | -0,25 | -0,16 | -0,21 | -0,15 |
Announcement Date | 05/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 09/05/23 | 07/08/23 | 09/11/23 | 28/02/24 | 06/05/24 | - | - | - | - | - |
Today 04:00 pm | ICU MEDICAL, INC.: Q1 2024 Earnings Release |
Today 04:01 pm | STAAR SURGICAL COMPANY: Q1 2024 Earnings Release |
Today 04:15 pm | BIO-RAD LABORATORIES, INC.: Q1 2024 Earnings Release |
2024-05-07 | STERIS PLC: Q4 2024 Earnings Release |
2024-05-08 04:00 pm | ESTABLISHMENT LABS HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-08 04:05 pm | PARAGON 28, INC.: Q1 2024 Earnings Release |
2024-05-08 | POLY MEDICURE LIMITED: Q4 2024 Earnings Release (Projected) |
2024-05-08 | METTLER-TOLEDO INTERNATIONAL, INC.: Q1 2024 Earnings Release |
2024-05-08 | SYSMEX CORPORATION: Q4 2024 Earnings Release |
2024-05-08 | INSULET CORPORATION: Q1 2024 Earnings Release |
Past sector events for RxSight, Inc.
Today 06:30 am | PREMIER, INC.: Q3 2024 Earnings Release |
Today | GLOBUS MEDICAL, INC.: Q1 2024 Earnings Release |
Today | AGILITI, INC.: Q1 2024 Earnings Release (Projected) |
Today | ADAPTHEALTH CORP.: Q1 2024 Earnings Release |
Today | ALPHATEC HOLDINGS, INC.: Q1 2024 Earnings Release |
2024-05-06 04:05 pm | RXSIGHT, INC.: Q1 2024 Earnings Release |
2024-05-06 04:05 pm | ARTIVION, INC.: Q1 2024 Earnings Release |
2024-05-06 07:00 am | AMPLIFON S.P.A.: Q1 2024 Earnings Release |
2024-05-06 06:00 am | INTEGRA LIFESCIENCES HOLDINGS CORPORATION: Q1 2024 Earnings Release |
2024-05-05 | TAIDOC TECHNOLOGY CORPORATION: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RXST Stock
- Calendar RxSight, Inc.